Chemotaxis by a CNS macrophage, the microglia
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Microglia demonstrate many characteristics similar to those seen in monocytes and tissue‐specific macrophages, including phagocytosis, production of oxygen radicals, and growth factors and expression of MHC antigens. We have examined the ability of microglia, cultured from the cerebral cortices of neonatal rats, to demonstrate another important functional characteristic of monocytic‐derived cells, that is, chemotaxis. Our results show that cultured rat microglia demonstrate chemotaxis to complement dependent chemoattractants such as recombinant C5a, zymosan activated serum, and to rat serum as well as to transforming growth factor‐beta, a chemoattractant produced by platelets, Microglia fail to migrate to bacterial dependent chemoattractants such as the N‐formyl peptides. The failure to respond is not dependenton maturational state of the microglia. Treatment with DMSO or casein, agents known to induce morphological and functional changes in cultured microglia reminescent of a “resting” and an “activated” macrophage, respectively, do not alter the response to fMet‐Leu‐Phe. In addition, the chemotactic response to serum in DMSO or casein‐treated cells is the same as the response seen in untreated day 10 cultured microglia or untreated age‐matched controls. The ability of microglia to migrate in response to inflammatory mediators suggests that these cells can move to sites of injury, thereby enabling them to participate in an inflammatory response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perry, V. H., Hume, D. A., & Gordon, S. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90215-5 · Cited by 902 · cited 1×
“and membrane antigenic similarities to monocytcs and macrophages (Giulian, 1987; Giulian and Baker, 1986; Ling, 1981; Ling et al., 1982; Oehtnichen, 1983; Perry et al., 1985; Perry and Gordon, 1988; Streit et al.. 1988).”
Interleukin 1 of the central nervous system is produced by ameboid microglia.
Giulian, D., Baker, T. J., Shih, L. C., & Lachman, L. B. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.2.594 · Cited by 859
Mannoji, H., Yeger, H., & Becker, L. E. (1986) · Acta Neuropathologica · doi:10.1007/bf00688060 · Cited by 206
Cited by
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730
Cytokines in inflammatory brain lesions: helpful and harmful
Merrill, J. E., & Benveniste, E. N. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10047-3 · Cited by 722
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587
“Three lines of evidence indicate that this effect of TGF-β1 might be mediated by activated microglia: as a chemoattractant for macrophages/microglia, TGF-β1 increased microglial activatio”
BackgroundExtracellular ATP or ADP Induce Chemotaxis of Cultured Microglia through Gi/o-Coupled P2Y Receptors
Honda, S., Sasaki, Y., Ohsawa, K., Imai, Y., Nakamura, Y., Inoue, K., & Kohsaka, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01975.2001 · Cited by 561
C5A Anaphylatoxin and Its Seven Transmembrane-Segment Receptor
Gerard, C., & Gerard, N. P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.004015 · Cited by 416
Function, structure and therapeutic potential of complement C5a receptors
Monk, P. N., Scola, A., Madala, P., & Fairlie, D. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707332 · Cited by 404
Microglia and inflammatory mechanisms in the clearance of amyloid β peptide
Rogers, J., Strohmeyer, R., Kovelowski, C. J., & Li, R. (2002) · Glia · doi:10.1002/glia.10153 · Cited by 381
Behar, T., Li, Y., Tran, H., Ma, W., Dunlap, V, Scott, C., & Barker, J. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-05-01808.1996 · Cited by 379
TRANSFORMING GROWTH FACTOR-βS IN NEURODEGENERATIVE DISEASE
FLANDERS, K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00066-x · Cited by 364
Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease
Fonseca, M. I., Zhou, J., Botto, M., & Tenner, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0901-04.2004 · Cited by 345
“Activation of the classical complement pathway by binding of C1q to fibrillar A can result in generation of chemotactic molecules that would recruit astrocytes and microglia to the area of the plaque (Yao et al., 1990; Gasque et al., 1997; O’Barr and Cooper, 2000).”
BackgroundInfluentialCentral neuron–glial and glial–glial interactions following axon injury
Aldskogius, H., & Kozlova, E. N. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00093-2 · Cited by 352
Complement, C1q, and C1q-Related Molecules Regulate Macrophage Polarization
Bohlson, S. S., O’Conner, S. D., Hulsebus, H. J., Ho, M.-M., & Fraser, D. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00402 · Cited by 297
Armstrong, R. C., Harvath, L., & Dubois‐Dalcq, M. E. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270319 · Cited by 287
Self-citationFonseca, M. I., Ager, R. R., Chu, S.-H., Yazan, O., Sanderson, S. D., LaFerla, F. M., Taylor, S. M., Woodruff, T. M., & Tenner, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901005 · Cited by 268
Cuzner, M. L., & Opdenakker, G. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00241-0 · Cited by 268
Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide
Bradt, B. M., Kolb, W. P., & Cooper, N. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.431 · Cited by 255
Localization and Cell Association of C1q in Alzheimer's Disease Brain
Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W., & Tenner, A. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0043 · Cited by 224
Glial activation in Alzheimer's disease: the role of Aβ and its associated proteins
Meda, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00307-4 · Cited by 222
Cuadros, M. A., Martin, C., Coltey, P., Almendros, A., & Navascués, J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903300110 · Cited by 192
Koizumi, S., Ohsawa, K., Inoue, K., & Kohsaka, S. (2013) · Glia · doi:10.1002/glia.22358 · Cited by 184
“…et al., 1995; Lauro et al., 2006), neurotrophic factors, such as NGF and EGF (Gilad and Gilad, 1995; Nolte et al., 1997), amyloid-b (Du Yan et al., 1997; Tiffany et al., 2001), complemental C5a (Yao et al., 1990), neuropeptide bra- dykinin (Ifuku et al., 2007), and neureglin-1 (Calvo et al., 2010).”
BackgroundThe complement cascade: Yin-Yang in neuroinflammation—neuro-protection and -degeneration
Alexander, J. J., Anderson, A. J., Barnum, S. R., Stevens, B., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05668.x · Cited by 177
“These behavioral alterations could also be cytokine driven (Zalcman et al. 1998), as deposition of immune complexes could lead to changes in cytokine profiles.”
BackgroundTGF‐β1 is an organizer of responses to neurodgeneration
Finch, C. E., Laping, N. J., Morgan, T. E., Nichols, N. R., & Pasinetti, G. M. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530408 · Cited by 165
Wie�ner, C., Gehrmann, J., Lindholm, D., T�pper, R., Kreutzberg, G. W., & Hossmann, K. A. (1993) · Acta Neuropathologica · doi:10.1007/bf00228578 · Cited by 151
Benoit (2011) · doi:10.1523/jneurosci.3932-10.2011 · Cited by 144
Complement Component C1q Modulates the Phagocytosis of Aβ by Microglia
Webster, S. D., Yang, A. J., Margol, L., Garzon-Rodriguez, W., Glabe, C. G., & Tenner, A. J. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7260 · Cited by 138
Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events
Tenner, A. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00301-3 · Cited by 81
Jeon, M.-T., Kim, K.-S., Kim, E. S., Lee, S., Kim, J., Hoe, H.-S., & Kim, D.-G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101333 · Cited by 76
Rezaie, P., & Male, D. (2002) · Neuroembryology and Aging · doi:10.1159/000051020 · Cited by 34
CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model
Ingersoll, S. A., Martin, C. B., Barnum, S. R., & Martin, B. K. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.08.007 · Cited by 33
Axons regulate the distribution of Schwann cell microtubules
Kidd, G., Andrews, S., & Trapp, B. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-00946.1996 · Cited by 23
Metadata
- Authors
- Yao, J., Harvath, L., Gilbert, D. L., & Colton, C. A.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1990-09
- Volume
- 27
- Issue
- 1
- Pages
- 36-42
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2099233769
- Cited by
- 211
- References
- 3
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.